BrainWaves Living Well 2026 is a unique scientific and educational conference that brings together researchers, educators, and partners.

A groundbreaking trial exploring the potential of blood tests to diagnose dementia is now underway in Tees, Esk and Wear Valleys NHS Foundation Trust.

New research reveals that repetitive strings of the amino acid serine can kill brain cells and accelerate the formation of toxic tau tangles associated with Alzheimer’s disease.

Gill Livingston, a professor of psychiatry of older people at University College London says: 'Alcohol is a toxin that can affect memory and raise your dementia risk.'

Researchers at DPUK and other institutions worldwide have published articles based on their work using DPUK resources. Here we list a wide selection of research papers that have either been funded or enabled by DPUK. You can search by author and topic.

An international trial involving 1,000 volunteers will aim to detect biomarkers associated with the condition.

Novo Nordisk's EVOKE trial didn't meet its primary endpoint - semaglutide didn't slow cognitive decline in people with early Alzheimer's. But the results revealed something intriguing: reductions in biomarkers of neurodegeneration, inflammation, and tau protein. The drug does something to Alzheimer's biology - the question is when to use it.